Breaking News: Company Buys Its Own Shares, Becomes Its Own Best Investor!

Transaction in Own Shares 01 November, 2024 Shell plc Announces Share Purchase for Cancellation Shell plc (the ‘Company’) announces that on 01 November 2024 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase: 01/11/2024 Number of Shares purchased: 840,000 Highest price paid: £26.2400…

Read More

Unveiling the Vital Role of XRP: Ripple CTO David Schwartz Confirms its Significance

Understanding the Importance of XRP within the XRP Ledger Ripple’s Chief Technology Officer, David Schwartz, on the Vital Role of XRP Ripple’s Chief Technology Officer, David Schwartz, has recently emphasized the critical importance of XRP within the XRP Ledger (XRPL) amidst ongoing discussions about its functionality. In a recent conversation with an XRP enthusiast, Schwartz…

Read More

Unpacking the Q3 2024 Earnings Call for Forum Energy Technologies Inc. (FET): A Playful and Relatable Recap

Forum Energy Technologies, Inc. (NYSE:FET) Q3 2024 Earnings Conference Call November 1, 2024 11:00 AM ET Company Participants: Rob Kukla – Director of Investor Relations Neal Lux – President and Chief Executive Officer Lyle Williams – Chief Financial Officer Conference Call Participants: Dave Storms – Stonegate John Daniel – Daniel Energy Partners Daniel Pickering –…

Read More

Uncovering the Heart of Enbridge Inc.’s Q3 2024 Earnings Call: A Deep Dive into the Emotions and Insights Shared

Enbridge Inc. (NYSE:ENB) Q3 2024 Earnings Call Transcript November 1, 2024 9:00 AM ET Company Participants: Rebecca Morley – Vice President, Investor Relations Greg Ebel – President, CEO & Director Pat Murray – Executive VP & CFO Colin Gruending – Executive VP & President of Liquids Pipelines Cynthia Hansen – Executive VP and President of…

Read More

Tiziana Life Sciences to Participate in BIO Europe 2024: Discussing Recent Clinical Advancements and Positive GLP-1 Combination Study Data

Charmingly Eccentric: Tiziana Life Sciences at BIO-Europe 2024 Breaking Boundaries in Immunomodulation Therapies New York, Nov. 01, 2024 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) Tiziana Life Sciences, a biotechnology company known for its eccentric charm and innovative approach to developing breakthrough immunomodulation therapies, is set to make waves at the BIO-Europe 2024…

Read More

Breaking News: Cleveland-Cliffs Successfully Acquires Stelco Holdings Inc.

Stelco Holdings Inc. Acquisition by Cleveland-Cliffs Inc. HAMILTON, Ontario–(BUSINESS WIRE)– Stelco Holdings Inc. (TSX: STLC) (“Stelco” or the “Company”) today announced that Cleveland-Cliffs Inc. (“Cliffs”) has completed its previously announced acquisition of Stelco (the “Arrangement”) pursuant to a plan of arrangement involving the Company, Cliffs, and 13421422 Canada Inc. (the “Purchaser”), a wholly owned subsidiary…

Read More